Qian J, Meng H, Xin L, et al. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation. Colloids Surf B Biointerfaces 2017; 160: 101-9.
Singh B, Garg B, Kaur R, Jain A, Kumar R, Prakash Om. Self-nanoemulsifying systems for oral bioavailability enhancement. Fabrication and Self-Assembly of Nanobiomaterials 2017; pp. 91-115.
Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 2010; 391: 203-11.
Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 2001; 50: 61-80.
AboulFotouh K. Allam AA, El-Badry M, El-Sayed AM. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil. Eur J Pharm Sci 2017; 15(109): 503-13.
Irina C, Abraham JD, Amnon H. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv 2015; 12(7): 1121-33.
Jeevana JB, Sreelakshmi K. Design and evaluation of selfnanoemulsifying drug delivery system of flutamide. J Young Pharm 2011; 3: 4-8.
Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007; 6: 231-48.
Bandyopadhyay S, Katare OP, Singh B. Optimized self-nanoemulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces 2012; 100: 50-61.
Nielsen FS, Petersen KB, Müllertz A. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm 2008; 69: 553-62.
Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release 2012; 158: 182-93.
Pangeni R. Jasjeet Sahni, Javed Ali K, Sharma S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Informa Healthcare 2014; 11(8): 1285-98.
Donatella P, Maria PF, Fatima A, et al. Resveratrol (trans-3,5,4-trihydroxystilbene; RSV) and its properties in oral disease. Exp Thera. Med 2017; 14(1): 3-9.
Monika Garg R, Sardana S. Research Problems Associated with Resveratrol (trans-3,5,4-trihydroxystilbene; RSV) and Various Strategies to Overcome those Problems. Curr Drug Deliv 2017; 14(3): 364-76.
Marier JF, Vachon P, Gritsas A. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002; 302: 369-73.
Singh G, Pai RS. Pharmacokinetics and in vivo bio distribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine. Drug Deliv 2013; 23(9): 3209-23.
Singh G, Pai RS. Trans-resveratrol self-nanoemulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv 2015; 22(4): 522-30.
Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-impact of different polymers. J Pharm Sci 2013; 102: 171-84.
Troche-Pesqueira E, Perez-Juste I, Navarro-Vazquez A. Cid. MM. A b-cyclodextrin-resveratrol inclusion complex and the role of geometrical and electronic effects on its electronic induced circular dichroism. RSC Advances 2013; 3: 10242-50.
Gehan F, Naser A, Mohamad AS, et al. Resveratrol β-cyclodextrin/lecithin complexes: A new approach for treatment of hepatic dysfunction. J Pharm Pharm Sci 2017; 6(1): 1-15.
Bandyopadhyay S, Katare O, Singh B. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv 2014; 11: 479-92.
Azeem A, Rizwan MF, Ahmad J. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 2009; 10(1): 69-76.
Singh G, Pai RS, Devi VK. Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design. J Adv Pharm Technol Res 2012; 3: 30-40. a
Dash RN, Mohammed H, Humaira T. Design, optimization, and evaluation of ezetimibe solid supersaturatable self-nanoemulsifying drug delivery for enhanced solubility and dissolution. Journal of Pharmaceutical Investigation 2016; 46(2): 153-68.
Patel G, Shelat P, Lalwani A. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment. Drug Deliv 2016; 23(8): 3027-42.
Khan AW, Kotta S, Ansari SH, Sharma RK, Ali A. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation. Drug Deliv 2015; 22(4): 552-61.
Puri R, Mahajan M, Sahajpal NS, Singh H, Singh H, Jain SK. Self-nanoemulsifying drug delivery system of docosahexanoic acid: development, in vitro- in vivo characterization. Drug Dev Ind Pharm 2016; 42(7): 1032-41.
Soltani Y, Goodarzi N, Mahjub R. Preparation and characterization of self nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin using hydrophobic complexation by cationic polymer of β-cyclodextrin. Drug Dev Ind Pharm 2017; 43(11): 1899-907.
Barzegar-Jalali M, Adbika K, Valizadeh H, et al. Kinetic analysis of drug release from nanoparticles. J Pharm Sci 2008; 11(1): 167-77.
Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res 1994; 11: 1132-42.
Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A Physicochem Eng Asp 2011; 392: 145-55.